GL1X · GenesisL1 explorer

MolNFT v1 · #20678 · protein

Crystal structure of the catalytic domain of mmp-16/MT3-mmp: characterization of mt-mmp specific features

1RM8 · Matrix metalloproteinase-16: “Crystal structure of the catalytic domain of mmp-16/MT3-mmp: characterization of mt-mmp specific features”. X-ray diffraction, 3 ligands (BAT, ZN, CA), 2 pockets (best druggability 0.50). MolNFT v1…

PDB
1RM8
Type
protein
Length
169 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Matrix metalloproteinase-16
EC
3.4.24.-
UniProt
P51512
Ligands
BAT, ZN, CA
Pockets
2 · best druggability 0.50

Structure

x-ray diffraction · 1 distinct chain · 24% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMatrix metalloproteinase-16 (EC 3.4.24.-)protein16924% helix, 16% strandP51512

Ligands and binding sites

  • BAT · 4-(N-hydroxyamino)-2R-isobutyl-2S-(2-thienylthiomethyl)succinyl-L-phenylalanine-N-methylamide · ligand · chains A
  • ZN · Zinc ion · metal · 2 copies · chains A
  • CA · Calcium ion · metal · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1820.500.8320ZN, BAT
2950.400.7714empty

Compared structures

  • 1RM8 · Crystal structure of the catalytic domain of MMP-16/MT3-MMP: Characterization of MT-MMP… · the same entry in another collection · chain A against A, TM-score 1.00
  • P51512 · AlphaFold monomer V2.0 prediction for matrix metalloproteinase-16 (P51512) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.